Author

Carsten Tschope

German Heart Center at Charit

Biography

Dr. Carsten Tschope is from Charite – Universitätsmedizin Berlin, Campus Benjamin Franklin, Department of Cardiology and Pulmology Hindenburgdamm, Berlin, located in Germany. His study is about Reduced Cardiac Performance after Differential Pharmacological Stress in Streptozotocin-Induced Diabetic Rats. He is also specialized in Myocarditis, Hfpef, Heart failure, Cardiomyopathy, Inflammation, Acute Heart Failure, Chronic Heart Failure, Heart Failure, Acute Myocardial Infarction, Clinical Cardiology, Cardiomyopathies, Cardiac Function, Myocarditis, Hypertension, and Myocardial Infarction. He published 503 articles in good journal and the articles are informative and got good citations.
Title
Cited by
Year
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart …
TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ...European heart journal 42 (36), 3599-3726, 2021202
2021
Myocarditis in athletes: a clinical perspective
M Halle, L Binzenhöfer, H Mahrholdt, M Johannes Schindler, K Esefeld, ...European journal of preventive cardiology 28 (10), 1050-1057, 2021202
54
2021
COVID-19 vs. classical myocarditis associated myocardial injury evaluated by cardiac magnetic resonance and endomyocardial biopsy
R Tanacli, P Doeblin, C Götze, V Zieschang, A Faragli, C Stehning, ...Frontiers in Cardiovascular Medicine 8, 737257, 2021202
33
2021
Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported …
B Heidecker, N Dagan, R Balicer, U Eriksson, G Rosano, A Coats, ...European journal of heart failure 24 (11), 2000-2018, 2022202
32
2022
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart
M Pesce, P Agostoni, HE Bøtker, B Brundel, SM Davidson, RD Caterina, ...Cardiovascular Research 117 (10), 2148-2160, 2021202
22
2021
Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction—a specific HFpEF phenotype
A Elsanhoury, V Nelki, S Kelle, S Van Linthout, C TschöpeFrontiers in cardiovascular medicine 8, 720690, 202
21
2021
20
2023
Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition
C Bruni, MH Buch, DE Furst, G De Luca, A Djokovic, RB Dumitru, A Giollo, ...Journal of Scleroderma and Related Disorders 7 (1), 24-32, 222
20
2022
Heart failure with preserved ejection fraction according to the HFA‐PEFF score in COVID‐19 patients: clinical correlates and echocardiographic findings
S Hadzibegovic, A Lena, TW Churchill, JE Ho, S Potthoff, C Denecke, ...European journal of heart failure 23 (11), 1891-1902, 212
20
2021
IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination
L Thurner, C Kessel, N Fadle, E Regitz, F Seidel, I Kindermann, S Lohse, ...New England Journal of Medicine 387 (16), 1524-1527, 222
20
2022
Impact of atrial fibrillation on outcome in takotsubo syndrome: data from the international takotsubo registry
I El‐Battrawy, VL Cammann, K Kato, KA Szawan, D Di Vece, A Rossi, ...Journal of the American Heart Association 10 (15), e014059, 2021202
16
2021
The non-invasive assessment of myocardial work by pressure-strain analysis: clinical applications
D Abawi, T Rinaldi, A Faragli, B Pieske, DA Morris, S Kelle, C Tschöpe, ...Heart Failure Reviews 27 (4), 1261-1279, 2022202
15
2022
Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis
K Pappritz, J Lin, M El‐Shafeey, H Fechner, U Kühl, A Alogna, ...ESC Heart Failure 9 (2), 925-941, 2022202
15
2022
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology
AJS Coats, S Heymans, D Farmakis, SD Anker, J Backs, J Bauersachs, ...European heart journal 43 (9), 863-867, 2022202
13
2022
Treatment of transthyretin amyloid cardiomyopathy: The current options, the future, and the challenges
C Tschöpe, A ElsanhouryJournal of Clinical Medicine 11 (8), 2148, 2022202
13
2022
Cardiac contractility modulation therapy improves health status in patients with heart failure with preserved ejection fraction: a pilot study (CCM‐HFpEF)
C Linde, M Grabowski, P Ponikowski, I Rao, A Stagg, C TschöpeEuropean Journal of Heart Failure 24 (12), 2275-2284, 2022202
11
2022
The spontaneous course of human herpesvirus 6 DNA-associated myocarditis and the effect of immunosuppressive intervention
A Elsanhoury, U Kühl, B Stautner, O Klein, A Krannich, D Morris, M Willner, ...Viruses 14 (2), 299, 2022202
8
2022
Cardiovascular magnetic resonance findings in non‐hospitalized paediatric patients after recovery from COVID‐19
F Seidel, T Kuehne, S Kelle, P Doeblin, V Zieschang, C Tschoepe, ...ESC Heart Failure (6), 553-55, 2021202
8
2021
Propensity score‐based analysis of 30‐day survival in cardiogenic shock patients supported with different microaxial left ventricular assist devices
G Nersesian, EV Potapov, V Nelki, J Stein, C Starck, V Falk, F Schoenrath, ...Journal of Cardiac Surgery 36 (11), 4141-4152, 2021202
7
2021
An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis
I Schatka, A Bingel, F Schau, S Bluemel, DR Messroghli, D Frumkin, ...Journal of Nuclear Cardiology 28, 2483-2496, 2021202
7
2021